Isopanduratin A From Kaempferia Pandurata As An Active Antibacterial
Isopanduratin A From Kaempferia Pandurata As An Active Antibacterial
Isopanduratin A From Kaempferia Pandurata As An Active Antibacterial
Abstract
An antibacterial compound active against Streptococcus mutans was isolated from Kaempferia pandurata and identified as isopanduratin
A using 1 H NMR, 13 C NMR and EI-MS. The minimum inhibitory concentration (MIC) of isopanduratin A was 4 mg/l which was much
lower than that of some other natural anticariogenic agents such as sanguinarine (12 mg/l), green tea extract and carvacrol (125 mg/l), thymol
(250 mg/l) and isoeugenol and eucalyptol (500 mg/l). The bactericidal test showed that isopanduratin A completely inactivated S. mutans
at 20 mg/l in 1 min. Significant inhibitory activity of isopanduratin A was also observed against S. sobrinus, S. sanguinis and S. salivarius
with an MIC of 4 mg/l. Damage to the cell membrane and cell wall of S. mutans by isopanduratin A was shown using transmission electron
microscopy (TEM). These results suggest that isopanduratin A could be employed as a potential antibacterial agent for preventing dental
caries.
© 2003 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Keywords: Antibacterial activity; Kaempferia pandurata; Isopanduratin A; Streptococcus mutans; Dental caries
0924-8579/$ – see front matter © 2003 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
doi:10.1016/j.ijantimicag.2003.08.011
378 J.-K. Hwang et al. / International Journal of Antimicrobial Agents 23 (2004) 377–381
cardomonin, pinostrobin, pinocembrin, alpinetin and 5- by elution with n-hexane and ethyl acetate solution (5:1, v/v)
hydroxy-7-methoxyflavanone are recognised as the bioac- and 10 ml volumes of eluant were collected in tubes. The
tive components of K. pandurata [13,14]. However, few collected tubes were divided into four fractions (Fr. I–IV)
studies have been conducted on the antibacterial activity of following silica TLC (thin layer chromatography, Merck, 60
K. pandurata. F254 ) and each fraction was assayed for antibacterial activity.
This research was aimed to isolate the antibacterial
compound from K. pandurata against S. mutans and to in- 2.4. Instrumentation
vestigate its effectiveness compared with other well-known
commercial antibacterial agents. 1H NMR and 13 C NMR spectra were measured using
JNM-LA500 (CD3 OD, 500 MHz, JEOL, Japan). Mass spec-
tra (EI-MS) were carried out using VG PlatformII (FISONS,
2. Materials and methods UK) at an ionization voltage of 40 eV.
Isopanduratin A 4 8
Since the antibacterial activity against S. mutans was cle- Chlorhexidine 1 2
arly observed in the ethyl acetate fraction, further sep- Vancomycin 1 2
aration was performed on this fraction using silica gel Hexamedine 6 12
Sanguinarine 12 24
column chromatography, and the purification procedures of Green tea extract 125 250
the active compound were monitored by MIC. Compound Carvacrol 125 250
II-b, prepared as described in the methodology, had a Thymol 250 500
molecular weight = 406 from the EI-MS spectrum (m/z, Isoeugenol 500 500
406, M+ ). Careful comparison of several spectral data of Eucalyptol 500 500
compound II-b including 13 C NMR, 1 H NMR and EI-MS
with those in the literature suggested the chemical structure
to be isopanduratin A (Fig. 1) or (2-methoxy-4,6-dihydroxy- agents. The activity was almost comparable with chlorhex-
phenyl)-(3 -methyl-2 -(3 -methylbut-2 -enyl)-6 -phenylcy- idine, vancomycin, and hexamedicine. However, antibiotics
clohex-3 -enyl) methanone [13,14]. The chemical structure are very limited in extended applications in oral care as they
was identified as an isomer of panduratin A [18]. may produce detrimental side effects such as discolouration
of teeth, reduction of the immune defence, disruption of nor-
mal ecology of plaque, diarrhoea, vomiting, etc. [20,21].
3.2. Antibacterial activity of isopanduratin A
Fig. 2 compares the bactericidal activities of isopanduratin
A and sanguinarine at the same concentration (20 mg/l). It is
Antibacterial activity of isopanduratin A was investigated
noteworthy that 20 mg/l of isopanduratin A showed consid-
in terms of minimum inhibitory concentration (MIC) and
erable killing of S. mutans in one minute. This fast bacteri-
minimum bactericidal concentration (MBC) compared with
cidal effect is of practical importance, since isopanduratin A
some commercially available agents. As shown in Table 1,
in toothpaste or mouthwash should be effective within a few
the MIC and MBC of isopanduratin A for S. mutans were
minutes. Similar bactericidal activity has also been reported
4 and 8 mg/l, respectively. Its MIC is much lower than
for xanthorrhizol from Curcuma xanthorrhiza [22]. Fig. 2
those of other natural antibacterial agents, such as green
also shows that the bactericidal activity of isopanduratin A
tea extract and carvacrol (125 mg/l), thymol (250 mg/l) and
against S. mutans was much more efficient than that of san-
isoeugenol and eucalyptol (500 mg/l). It is also interesting
guinarine. Accordingly, isopanduratin A might have more
to note in Table 1 that isopanduratin A (4 mg/l) had a sig-
potential application in oral care products in place of san-
nificantly lower MIC than sanguinarine (12 mg/l), which is
guinarine. The strong bactericidal activity of isopanduratin
a natural compound isolated from Sanguinaria canadensis
A at a concentration as low as 5 mg/l and dose-dependence
widely used for industrial toothpaste and mouthwash prod-
is shown in Fig. 3.
ucts [6,19]. This indicates that isopanduratin A has much
stronger antibacterial activity than other natural commercial
0
-1
-2
Log survival ratio
-3
-4
-5
-6
-7
0 2 4 6 8 10 12
Treatment time (min)
-1
-2
Log survival ratio
-3
-4
-5
-6
-7
0 2 4 6 8 10 12
Treatment time (min)
3.3. Morphology
Fig. 4. Transmission electron microscopy of isopanduratin A-treated S.
mutans (magnification: 40,000×): (a) control (0.05% DMSO); (b) 10 mg/l
Transmission electron microscopy (TEM) was carried isopanduratin A.
out to see any morphological changes in S. mutans brought
about by isopanduratin A treatment. Compared with the
intact cell in (Fig. 4a), significant morphological changes caused by the growth of Streptococcus spp. Further studies
were observed in the cells treated with 10 mg/l isopan- are necessary for elucidating the antibacterial mechanism of
duratin A (Fig. 4b). After isopanduratin A treatment, the isopanduratin A at the molecular level.
cell surface was remarkably disintegrated and the cytoplasm
membrane was detached from the cell wall. A similar re-
sult was also reported for kuwanon G from Morus alba Acknowledgements
[23].
In this study, isopanduratin A exhibited specific activity This work was supported by the Korea Science and Engi-
against the oral bacteria S. mutans, S. sobrinus, S. sanguinis neering Foundation (KOSEF) through the Bioproducts Re-
and S. salivarius. In particular, isopanduratin A showed high search Center at Yonsei University.
activity against S. mutans at 20 mg/l in one minute. These
data suggest that isopanduratin A could be employed as
a natural anticariogenic agent for preventing dental caries References
[6] Joann LD, Sigmund SS. Comparative in vitro activity of sanguinar- [14] Pandji CW, Grimm C, Wray V. Insecticidal constituents from four
ine against oral microbial isolates. Antimicrob Agents Chemother species of the Zingiberaceae. Phytochemistry 1993;34:415–9.
1985;27:663–5. [15] Bert F, Woolfrey MD, Joan M. Comparison of minimum inhibitory
[7] Eley BM. Antibacterial agents in the control of supragingival plaque-a concentration values determined by three antimicrobic dilution meth-
review. Br Dent J 1999;186:286–96. ods for Pseudomonas aeruginosa. Am J Clin Pathol 1981;75:39–44.
[8] Mascarenhas AK, Allen CM, Loudon J. The association between [16] Chand SI, Lusunzi DA, Veal LR. Rapid screening of the antimicrobial
Viadent use and oral leukoplakia. Epidemiology 2001;12:741– activity of extracts and natural products. J Antibiot 1994;47:1295–
3. 304.
[9] Munro IC, Delzell ES, Nestmann ER. Viadent usage and oral leuko- [17] Jones RN, Pfaller MA, Jacobs MR. Cefditoren in vitro activity and
plakia: a spurious association. Regul Toxicol Phamacol 1999;30:182– spectrum: a review of internation studies using reference methods.
96. Diagn Microbiol Infect Dis 2001;41:1–14.
[10] Trakoontivakorn G, Nakahara K, Shinmoto H. Structural analysis of [18] Jaipetch T, Kanghae S, Pancheroen O. Constituents of Boesenbergia
a novel antimutagenic compound, 4-hydroxypanduratin A, and an- pandurata (syn. Kaempferia pandurata): Isolation, crystal structure
timutagenic activity of flavonoids in a Thai spice, fingerroot (Boe- and synthesis of (±)-boesenbergin A. Aust J Chem 1982;35:351–61.
senbergia pandurata Schult.) against mutagenic heterocyclic amines. [19] Southard GL, Boulware RT, Walbonr DR. Sanguinarine, a new an-
J Agric Food Chem 2001;49:3046–50. tiplaque agent: retention and plaque specificity. J Am Dent Assoc
[11] Murakami A, Kondo A, Nakamura Y. Anti-tumor promoting prop- 1984;108:338–43.
erties of edible plants from Thailand, and identification of an active [20] Marsh PD. Microbiological aspects of the chemical control of plaque
constituent, cardamonin, of Boesenbergia pandurata. Biosci Biotech and gingivitis. J Dent Res 1992;71:1431–8.
Biochem 1993;57:1971–3. [21] Daneshmand N, Jorgensen MG, Nowzari H. Initial effect of con-
[12] Panthong A, Tassaneeyakul W, Kanjanapothi D. Anti-inflammatory trolled release chlorhexidine on subgingival microorganisms. J Peri-
activity of 5,7-dimethoxyflavone. Planta Med 1989;55:133–6. odontal Res 2002;37:375–9.
[13] Pancharoen O, Picker K, Reutrkul V. Constituents of Zingiberaceae. [22] Hwang JK, Shim JS, Baek NI, Pyun YR. Xanthorrhizol: a potential
Diastereomers of [7-hydroxy-5-methoxy-2-methyl-2-(4 -methylpent- antibacterial agent from Curcuma xanthorrhiza against Streptococcus
3 -enyl)-2H-chromen-8-yl][3 -methyl-2 -(3 -methylbut-2 -enyl)- mutans. Planta Med 2000;66:196–7.
6 -phenylcyclo-hex-3 -enyl]methanone (panduratin B), a constituent [23] Park KM, You JS, Lee HY, Baek NI, Hwang JK, Kuwanon G. An
of the red rhizomes of a variety of Boesenbergia pandurata. Aust J antibacterial agent from the root bark of Morus alba against oral
Chem 1987;40:455–9. pathogens. J Ethnopharmacol 2003;84:181–5.